Metoprolol succinate clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Succinate Clinical Uses: Hypertension, Angina, and Heart Failure
Metoprolol succinate is a beta1-selective adrenoceptor blocker widely used in cardiovascular medicine. Its extended-release formulation allows for once-daily dosing, improving patient compliance and maintaining stable drug levels throughout the day Vinereanu2020Huang2020Zhao2021.
Hypertension Treatment with Metoprolol Succinate
Metoprolol succinate is commonly prescribed to lower blood pressure in patients with hypertension. Lowering blood pressure with this medication reduces the risk of fatal and non-fatal cardiovascular events, such as strokes and heart attacks Vinereanu2020Papadopoulos2009Huang2020+2 MORE. It can be used alone or in combination with other antihypertensive agents, such as diuretics, to enhance blood pressure control .
Angina Pectoris and Coronary Heart Disease
This medication is also indicated for the management of angina pectoris, including both stable and vasospastic forms. Clinical studies show that metoprolol succinate reduces the frequency and severity of angina attacks, with some evidence suggesting it may be more effective than metoprolol tartrate in reducing clinically significant angina episodes Vinereanu2020Papadopoulos2009Grabysa2020+3 MORE. It is also used in patients with coronary heart disease to decrease cardiovascular events and mortality Huang2020Bocharov2021.
Heart Failure: Improving Outcomes and Reducing Mortality
Metoprolol succinate is a cornerstone therapy for stable, symptomatic heart failure, particularly in patients with New York Heart Association (NYHA) Class II or III symptoms due to ischemic, hypertensive, or cardiomyopathic origins Vinereanu2020Gao2024Papadopoulos2009+2 MORE. Studies consistently show that it reduces mortality and morbidity in heart failure patients, making it a key component of guideline-directed medical therapy Gao2024Bocharov2021Zhao2021.
Arrhythmias: Atrial Fibrillation and Ventricular Arrhythmias
Metoprolol succinate is effective in reducing the incidence of new atrial fibrillation episodes in high-risk patients and is used for rate control in atrial fibrillation Gao2024Bocharov2021. It is also beneficial in treating ventricular arrhythmias, especially after myocardial infarction, by improving heart rate control, correcting QT dispersion, and reducing adverse reactions compared to other treatments Skotnikov2024Bocharov2021.
Other Clinical Uses
Beyond cardiovascular diseases, metoprolol succinate is sometimes used in the management of migraine and thyrotoxicosis due to its beta-blocking properties . Its extended-release formulation is preferred for these indications due to its stable pharmacokinetic profile Bubnova2022Zhao2021.
Conclusion
Metoprolol succinate is a versatile and well-studied beta-blocker with proven benefits in hypertension, angina pectoris, heart failure, and arrhythmias. Its extended-release formulation offers convenient once-daily dosing and consistent therapeutic effects, making it a mainstay in the management of various cardiovascular conditions Vinereanu2020Gao2024Papadopoulos2009+7 MORE.
Sources and full results
Most relevant research papers on this topic
Role of Metoprolol Succinate in the Treatment of Heart Failure and Atrial Fibrillation: A Systematic Review.
Metoprolol succinate remains a useful drug for treating heart failure and atrial fibrillation, with significant mortality and morbidity benefits compared to other beta-blockers.
Selection of modern β-blocker dosing regimen in various clinical situations (exemplified by metoprolol succinate)
Optimal doses of beta-blockers, such as metoprolol succinate, are often underestimated in various clinical conditions, leading to unjustified undertreatment.
Clinical Efficacy of Metoprolol Succinic Acid Sustained Release Tablets Combined with Trimetazidine in the Treatment of Gastrointestinal Tumors with Angina Pectoris
Metoprolol succinate sustained-release tablets combined with trimetazidine improve angina pectoris treatment efficacy and are safe for clinical use in gastrointestinal tumors with angina pectoris.
DOI
Optimal dosage of β-blockers using metoprolol CR/XL as an example – what, for whom and when?
Metoprolol CR/XL is an effective and cardioselective beta-blocker for treating hypertension, chronic heart failure, and coronary artery disease, with a single daily dose ensuring high compliance.
DOI
Comparative evaluation of the effectiveness of metoprolol succinate and metoprolol tartrate in patients with vasospastic angina
Metoprolol succinate has a significant advantage in reducing clinically significant angina attacks, but no significant difference in cardiovascular events or death between the two drugs.
Efficacy of Metoprolol Succinate Sustained Release Tablets Combined with Wenxin Granules in the Treatment of Coronary Heart Disease Arrhythmia
Metoprolol succinate sustained-release tablets combined with Wenxin Granules significantly improves dynamic electrocardiogram indexes, clinical efficacy, and safety in treating coronary heart disease patients with arrhythmia.
DOI